Iodine-deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a vascular endothelial growth factor-hypoxia inducible factor-1-dependent, but not a reactive oxygen species-dependent, pathway

Thyroid

Volumn 22, Issue 7, 2012, Pages 699-708

  Gérard, Anne Catherine ^a   Humblet, Kevin ^a   Wilvers, Cindy ^a   Poncin, Sylvie ^a   Derradji, Hanane ^b   De Ville De Goyet, Christine ^a   Abou El Ardat, Khalil ^b,c   Baatout, Sarah ^b,c   Sonveaux, Pierre ^a   Denef, Jean François ^a   Colin, Ides M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTITHYROID AGENT; ECHINOMYCIN; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CARCINOMA CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; GOITER; HUMAN; HUMAN CELL; IODINE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID CARCINOMA; THYROID CELL;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; DEFICIENCY DISEASES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IODINE; LASER-DOPPLER FLOWMETRY; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SYMPORTERS; THYROID GLAND; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863485749     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0387     Document Type: Article

References (46)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
2. Brown RL, De Souza JA, Cohen EE 2011 Thyroid cancer: Burden of illness and management of disease. J Cancer 2:193-199.
3. Andersson M, Takkouche B, Egli I, Allen HE, De Benoist B 2005 Current global iodine status and progress over the last decade towards the elimination of iodine deficiency. Bull World Health Organ 83:518-525.
4. Venturi S, Donati FM, Venturi A, Venturi M, Grossi L, Guidi A 2000 Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Path 4:11-17.
5. Knobel M, Medeiros-Neto G 2007 Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arq Bras Endocrinol Metabol 51:701-712.
6. Franceschi S 1998 Iodine intake and thyroid carcinoma-A potential risk factor. Exp Clin Endocrinol Diabetes 106 Suppl 3:S38-S44.
7. Williams ED, Abrosimov A, Bogdanova T, Demidchik EP, Ito M, Li Volsi V, Lushnikov E, Rosai J, Tronko MD, Tsyb AF, Vowler SL, Thomas GA 2008 Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid 18:847-852.
8. Feldt-Rasmussen U 2001 Iodine and cancer. Thyroid 11:483-486.
9. Schaller RT, Jr., Stevenson JK 1966 Development of carcinoma of the thyroid in iodine-deficient mice. Cancer 19: 1063-1080.
10. Kopp PA 2008 Reduce, recycle, reuse-iodotyrosine deiodinase in thyroid iodide metabolism. N. Engl. J. Med 358: 1856-1859.
11. Pedraza PE, Obregon MJ, Escobar-Morreale HF, del Rey FE, De Escobar GM 2006 Mechanisms of adaptation to iodine deficiency in rats: Thyroid status is tissue specific. Its relevance for man. Endocrinology 147:2098-2108.
12. Gnidehou S, Caillou B, Talbot M, Ohayon R, Kaniewski J, Noel-Hudson MS, Morand S, Agnangji D, Sezan A, Courtin F, Virion A, Dupuy C 2004 Iodotyrosine dehalogenase 1(DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. FASEB J 18:1574-1576.
13. Colin IM, Gerard AC 2010 The thyroid angiofollicular units, a biological model of functional and morphological integration. Bulletin et Mémoires De l?Académie royale De Belgique 165:218-230.
14. Gerard AC, Denef JF, Many MC, Gathy P, De Burbure C, van den Hove MF, Coppee F, Ledent C, Colin IM 2003 Relationships between cell division, expression of growth factors and microcirculation in the thyroids of Tg-A2aR transgenic mice and patients with Graves? disease. J Endocrinol 177:269-277.
15. Gerard AC, Many MC, Daumerie C, Costagliola S, Miot F, De vijlder JJ, Colin IM, Denef JF 2002 Structural changes in the angiofollicular units between active and hypofunctioning follicles align with differences in the epithelial expression of newly discovered proteins involved in iodine transport and organification. J Clin Endocrinol Metab 87:1291-1299.
16. Gerard AC, Xhenseval V, Colin IM, Many MC, Denef JF 2000 Evidence for co-ordinated changes between vascular endothelial growth factor and nitric oxide synthase III immunoreactivity, the functional status of the thyroid follicles, and the microvascular bed during chronic stimulation by low iodine and propylthiouracyl in old mice. Eur J Endocrinol 142:651-660.
17. Gerard AC 2002 Autocrine/paracrine regulation of the thyroid. Expression of growth and vasoactive factors, and of differentiation markers in normal and pathological tissues. Thesis, Université catholique De Louvain, Louvain-La-Neuve, Belgium.
18. Gerard AC, Poncin S, Caetano B, Sonveaux P, Audinot JN, Feron O, Colin IM, Soncin F 2008 Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. Am J Pathol 172:748-760.
19. Gerard AC, Poncin S, Audinot JN, Denef JF, Colin IM 2009 Iodide deficiency-induced angiogenic stimulus in the thyroid occurs via HIF- and ROS-dependent VEGF-A secretion from thyrocytes. Am J Physiol Endocrinol Metab 296:E1414-E1422.
20. Sonveaux P, Frerart F, Bouzin C, Brouet A, Dewever J, Jordan BF, Gallez B, Feron O 2007 Irradiation promotes Akttargeting therapeutic gene delivery to the tumor vasculature. Int J Radiat Oncol Biol Phys 67:1155-1162.
21. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals crosscontamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93:4331-4341.
22. Kong D, Park EJ, Stephen AG, Calvani M, Cardellina JH, Monks A, Fisher RJ, Shoemaker RH, Melillo G 2005 Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res 65:9047-9055.
23. Gerard AC, Boucquey M, van Den Hove MF, Colin IM 2006 Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-1alpha/IFN-gamma, an effect partially mediated by nitric oxide. Am J Physiol Endocrinol Metab 291:E242-E253.
24. Carmeliet P, Collen D 2000 Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann NY Acad Sci 902:249-262.
25. Yeh SH, Hung JJ, Gean PW, Chang WC. 2008 Hypoxia-inducible factor-1alpha protects cultured cortical neurons from lipopolysaccharide-induced cell death via regulation of NR1 expression. J Neurosci 28:14259-14270.
26. Schroder-van der Elst JP, van der Heide D, Kastelijn J, Rousset B, Obregon MJ 2001 The expression of the sodium/iodide symporter is up-regulated in the thyroid of fetuses of iodine-deficient rats. Endocrinology 142:3736-3741.
27. Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE 1999 Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404-3410.
28. Eng PH, Cardona GR, Previti MC, Chin WW, Braverman LE 2001 Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 144:139-144.
29. Serrano-Nascimento C, Calil-Silveira J, Goulart-Silva F, Nunes MT 2012 New insights about the posttranscriptional mechanisms triggered by iodide excess on sodium/iodide symporter (NIS) expression in PCCl3 cells. Mol Cell Endocrinol 349:154-161.
30. Poncin S, Colin IM, Gerard AC 2009 Minimal oxidative load: A prerequisite for thyroid cell function. J Endocrinol 201:161-167.
31. Bunone G, Vigneri P, Mariani L,Buto S, Collini P, Pilotti S, Pierotti MA, Bongarzone I 1999 Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155:1967-1976.
32. Hsueh C, Lin JD, Wu IC, Chao TC, Yu JS, Liou MJ, Yeh CJ 2011 Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma. J Surg Oncol 103:395-399.
33. Salajegheh A, Smith RA, Kasem K, Gopalan V, Nassiri MR, William R, Lam AK 2011 Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypes. Eur J Surg Oncol 37:93-99.
34. Erdem H, Gundogdu C, Sipal S 2011 Correlation of Ecadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma. Exp Mol Pathol 90:312-317.
35. Folkman J, Shing Y 1992 Angiogenesis. J Biol Chem 267: 10931-10934.
36. Naumov GN, Folkman J, Straume O, Akslen LA 2008 Tumor-vascular interactions and tumor dormancy. APMIS 116: 569-585.
37. Gerhardt H, Semb H 2008 Pericytes: Gatekeepers in tumour cell metastasis? J Mol Med 86:135-144.
38. Gerhardt H, Betsholtz C 2003 Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15-23.
39. von Tell D, Armulik A, Betsholtz C 2006 Pericytes and vascular stability. Exp Cell Res 312:623-629.
40. Antonelli-Orlidge A, Saunders KB, Smith SR, D?Amore PA 1989 An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548.
41. Burrows N, Resch J, Cowen RL,von Wasielewski R, Hoanh-Vu C, West CM, Williams KJ, Brabant G 2010 Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas. Endocr Relat Cancer 17:61-72.
42. Jubb AM, Pham TQ, Hanby AM, Frantz GD, Peale FV, Wu TD, Koeppen HW, Hillan KJ 2004 Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours. J Clin Pathol 57:504-512.
43. Scarpino S, Cancellario dF, Di NA, Pasquini A, Marzullo A, Ruco LP 2004 Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. J Pathol 202:352-358.
44. Poulaki V, Mitsiades CS, McMullan C, Sykoutri D, Marzullo A, Ruco LP 2003 Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas. J Clin Endocrinol Metab 88:5392-5398.
45. Pereira ER, Liao N, Neale GA, Hendershot LM 2010 Transcriptional and post-Transcriptional regulation of proangiogenic factors by the unfolded protein response. PLoS One 5:e12521.
46. Ghosh R, Lipson KL, Sargent KE, Mercurio AM, Hunt JS, Ron D, Urano F 2010 Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One 5:e9575.